Evidence map›Paper›PMID 32864382›Full record

ArticleERJ open research2020

Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis.

Rebeca Passarelli Mantovani, Angela Sandri, Marzia Boaretti, Gloria Burlacchini, Veronica Li Vigni, Mattia Scarazzai, Paola Melotti, Caterina Signoretto, Maria M Lleo

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Differential Evolution ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rebeca Passarelli MantovaniDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Angela SandriDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Marzia BoarettiDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Gloria BurlacchiniDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Veronica Li VigniDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Mattia ScarazzaiDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Paola MelottiCystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata (AOUI) of Verona, Verona, Italy.
Caterina SignorettoDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
Maria M LleoDept of Diagnostics and Public Health, Microbiology Section, University of Verona, Verona, Italy.
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · ITHealth First · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParanasal sinuses act as bacterial reservoirs and contribute to transmitting bacteria to the lower airway of patients with cystic fibrosis (CF). Also, passage of bacteria from the oral cavity to the lungs may occur.

methodsWe evaluated the presence of

resultsAbout 80% of the patients were positive for at least one of the bacterial species examined in nasal lavage and sputum. Among the subjects with positive sputum, 74% presented the same species in the nasal lavage and saliva, and 26% on their toothbrush.

conclusionNasal and oral sites act as bacterial reservoirs, favouring the transmission of potentially pathogenic microorganisms to the lower airway. The lack of eradication from these sites might undermine the antibiotic therapy applied to treat the lung infection, allowing the persistence of the bacteria within the patient if colonisation of these sites is not assessed, and no specific therapy is performed.

Identifiers

PMID32864382
PMCPMC7445119
OpenAlexW3080872337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.